IGF1 and metabolic syndrome: Central obesity promotes sleep apnea through mechanical action and low-grade inflammation, while OSAS promotes metabolic syndrome through sympathetic nervous overactivity, reactive oxygen production, low-grade inflammation, and alterations in cortisol and IGF-1 circadian fluctuations.